XML 102 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Allocated Share-based Compensation Expense
Our stock-based compensation expense is recorded in SG&A on our Consolidated Statements of Income:
 
 
Years ended December 31,
(In millions)
 
2019
 
2018
 
2017
Restricted stock units
 
$
30

 
$
21

 
$
12

Performance-based restricted stock units
 
6

 
9

 
10

Cash-settled performance-based restricted stock units
 
31

 
19

 
55

Other
 
—

 
—

 
2

Total stock-based compensation expense
 
$
67

 
$
49

 
$
79

Tax benefit on stock-based compensation
 
(2
)
 
(22
)
 
(8
)
Equity Awards Outstanding and Exercisable
A summary of cash-settled PRSU award activity for the year ended December 31, 2019 is presented below:
 
 
Number of Cash-Settled PRSUs
Outstanding as of December 31, 2018
 
753,276

Granted
 
—

Vested
 
(317,949
)
Forfeited and canceled
 
—

Outstanding as of December 31, 2019
 
435,327


A summary of RSU and PRSU award activity for the year ended December 31, 2019 is presented below:
 
 
RSUs
 
PRSUs
 
 
Number of RSUs
 
Weighted-Average Grant Date Fair Value
 
Number of PRSUs
 
Weighted-Average Grant Date Fair Value
Outstanding as of December 31, 2018
 
1,085,628

 
$
68.24

 
1,036,925

 
$
43.51

Granted
 
1,148,380

 
50.85

 
1,030,368

 
15.93

Vested
 
(195,609
)
 
65.62

 
(407,245
)
 
30.40

Forfeited and canceled
 
(308,984
)
 
72.90

 
(75,783
)
 
35.21

Outstanding as of December 31, 2019
 
1,729,415

 
$
56.17

 
1,584,265

 
$
29.35

A summary of stock option award activity for the year ended December 31, 2019 is presented below:
 
 
 Stock Options
 
 
Number of Stock Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Term
Outstanding as of December 31, 2018
 
702,318

 
$
12.70

 
3.05
Granted
 
—

 
—

 
 
Exercised
 
(125,125
)
 
14.46

 
 
Forfeited
 
(1,438
)
 
22.83

 
 
Outstanding as of December 31, 2019
 
575,755

 
$
12.29

 
2.47
Options exercisable as of December 31, 2019
 
575,755

 
$
12.29

 
2.47